
Dec. 7 at 4 pm ET | A Conversation with FDA Acting Commissioner Janet Woodcock

Dec. 7 at 2:30 pm ET | A Conversation with US Representatives Diana DeGette and Fred Upton on Cures 2.0 Legislation

Dec. 7 at 2:30 pm ET | The Road Ahead for Improving Access to Testing and Treatment for Rare Diseases

Dec. 7 at 1:00 pm ET | Disruptive Developments in Cancer Research

Dec. 7 at 1:00 pm ET | Achieving More Person-Centered Prevention and Treatment of Chronic Diseases

Dec. 7 at 11:30 am ET | Reimagining Public Health Partnerships: Lessons Learned from the Pandemic

Dec. 7 at 11:30 am ET | Pain Points and Potential for Cell and Gene Therapies

Dec. 7 at 9:30 am ET | Combatting the Infodemic: Challenges of Public Communication About Science and Health

Dec. 7 at 9:30 am ET | Where Are We and Where We Are Headed with Patient Engagement in Research?

The Post-COVID Recovery: California's Lagging Employment Rate

Tech Regulation Digest: New York State’s Social Media Bill and Section 230
